Bailey John, Nafees Sadia Bashir, Gill Simon, Jones Lucy, Poole Rob
Centre for Mental Health and Society, Bangor University, Bangor, UK
Centre for Mental Health and Society, Bangor University, Bangor, UK.
BJGP Open. 2022 Dec 20;6(4). doi: 10.3399/BJGPO.2022.0134. Print 2022 Dec.
There are concerns about continuing increases in the number of patients prescribed long-term opioids and the prescribing of 'strong' opioids for chronic pain. Little is known about patients who are prescribed these long-term, high-dose drugs.
To understand patterns of opioid prescribing that lead to long-term, high-dose use.
DESIGN & SETTING: A mixed-method study of the opioid prescription histories of patients using high doses in a North Wales GP practice.
All patients on high-dose opioids during the census week were identified. Summary graphs of the prescription histories were prepared. Qualitative analysis was conducted individually by four researchers. A workshop was held to arrive at a consensus about common features and to inform further quantitative analysis.
A quarter of high-dose regimens were initiated outside the practice, either in a different primary care practice or in secondary care. The majority of the remaining patients showed a pattern of dose increases to high levels over a short period (median 3.5 months). None showed a pattern of gradual increases over a longer timescale. Most of the patients remained on high doses continuously once a daily dose of ≥120 mg oral morphine equivalent (OME) was reached.
These findings suggest that high-dose opioid regimens develop quickly in response to unknown clinical factors. An expected insidious upward drift in dose was not seen. The findings have implications for the prevention of potentially dangerous long-term, high-dose opioid prescribing. A dose of 60 mg OME or more is suggested as a useful 'red flag'.
人们对长期服用阿片类药物的患者数量持续增加以及为慢性疼痛开具“强效”阿片类药物的情况感到担忧。对于那些被开具这些长期高剂量药物的患者,我们知之甚少。
了解导致长期高剂量使用阿片类药物的处方模式。
对北威尔士一家全科医生诊所中高剂量使用阿片类药物患者的处方历史进行的一项混合方法研究。
确定普查周期间所有服用高剂量阿片类药物的患者。绘制处方历史的汇总图表。由四名研究人员分别进行定性分析。举办了一次研讨会,就共同特征达成共识,并为进一步的定量分析提供信息。
四分之一的高剂量用药方案是在本诊所之外开始的,要么是在另一家基层医疗诊所,要么是在二级医疗机构。其余大多数患者在短时间内(中位时间3.5个月)呈现出剂量增加至高剂量水平的模式。没有患者在较长时间内呈现出逐渐增加的模式。一旦每日口服吗啡当量(OME)达到≥120毫克,大多数患者会持续维持高剂量。
这些发现表明,高剂量阿片类药物用药方案会迅速因未知临床因素而形成。未观察到预期的剂量隐匿性上升趋势。这些发现对预防潜在危险的长期高剂量阿片类药物处方具有启示意义。建议将60毫克或更高的OME剂量作为一个有用的“警示信号”。